IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
Authors
Keywords
3, 3′-Diindolylmethane, ovarian cancer, STAT3, metastasis, IL6, MMP
Journal
CELLULAR ONCOLOGY
Volume 39, Issue 1, Pages 47-57
Publisher
Springer Nature
Online
2015-10-28
DOI
10.1007/s13402-015-0251-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation
- (2014) Yan Li et al. CELLULAR ONCOLOGY
- Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report
- (2014) Mazdak Momeni et al. CELLULAR ONCOLOGY
- Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
- (2013) Aamir Ahmad et al. Anti-Cancer Agents in Medicinal Chemistry
- HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ER and Inducing IL-6 Expression
- (2013) N. Shah et al. CANCER RESEARCH
- The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
- (2013) Jiabo Di et al. CELLULAR ONCOLOGY
- Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies
- (2012) Q. J. Wu et al. ANNALS OF ONCOLOGY
- STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma
- (2012) Bing Tu et al. CANCER LETTERS
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- DIMming Ovarian Cancer Growth
- (2012) Prabodh K. Kandala et al. CURRENT DRUG TARGETS
- Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
- (2012) Eveline M. Dijkgraaf et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
- (2012) Yue Wang et al. CYTOKINE
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- STAT3 negatively regulates thyroid tumorigenesis
- (2012) J. P. Couto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 3,3′-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells
- (2012) Laura M. Beaver et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer
- (2009) Sanjeev Banerjee et al. CANCER RESEARCH
- STAT3 Regulation of Glioblastoma Pathogenesis
- (2009) Nuria la Iglesia et al. CURRENT MOLECULAR MEDICINE
- Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
- (2009) Monica Musteanu et al. GASTROENTEROLOGY
- Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
- (2009) M Walter et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now